Albuminuria in moderate and severe obstructive sleep apnoea (OSA) patients

Robert Plywaczewski (Warsaw, Poland), Robert Plywaczewski, Anna Czyzak-Gradkowska, Przemyslaw Bielen, Pawel Sliwinski

Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing
Session: Inflammation, biomarkers and hypoxia in sleep disordered breathing
Session type: Thematic Poster Session
Number: 2325

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Robert Plywaczewski (Warsaw, Poland), Robert Plywaczewski, Anna Czyzak-Gradkowska, Przemyslaw Bielen, Pawel Sliwinski. Albuminuria in moderate and severe obstructive sleep apnoea (OSA) patients. Eur Respir J 2015; 46: Suppl. 59, 2325

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA)
Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing
Year: 2015


Daytime sleepiness and cardiovascular complications in moderate to severe obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing
Year: 2013


Progression of subclinical atherosclerosis in obstructive sleep apnoea (OSA)
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016

Determinants of subclinical atherosclerosis in patients with obstructive sleep apnoea
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies
Year: 2015


Association between smoking and concomitant diseases in obstructive sleep apnoea (OSA)
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015

The clinical presentation of obstructive sleep apnea syndrome is different in diabetic patients
Source: International Congress 2016 – Effect of sleep apnoea on life-span and comorbidities
Year: 2016

Prevalence of symptomatic gastroesophageal reflux disease (GERD) in severe obstructive sleep apnea (OSA)
Source: International Congress 2016 – Comorbid sleep apnoea in specific clinical entities and differential diagnosis of sleep disorders
Year: 2016

Predictors of nocturnal hypertension in obstructive sleep apnea patients with metabolic syndrome
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013

Use of clinical predictors on diagnosis of OSAS in patients with chronic obstructive pulmonary disease, asthma and cardiovascular diseases
Source: International Congress 2014 – Sleep disordered breathing 3
Year: 2014


Evaluation of lipid profile in patients with obstructive sleep apnea syndrome
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015


Prevalence of arterial hypertension in obstructive sleep apnoea (OSA) patients – Impact of diabetes and obesity
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013


Subclinical atherosclerosis in obstructive sleep apnea (OSA): The EPIOSA study
Source: International Congress 2015 – Paediatric and adult sleep-disordered breathing: from inflammation to treatment and telemedicine
Year: 2015

Prevalence of metabolic syndrome with obstructive sleep apnea in a Korean population
Source: Annual Congress 2013 –Sleep disordered breathing in special situations III
Year: 2013


The effects of obstructive sleep apnea on cardiovascular functioning in children with obesity
Source: Annual Congress 2013 –Assessing sleep disordered breathing and lung function in children
Year: 2013

Alteration of inflammatory mediators in patients with obstructive sleep apnea
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013


Obstructive sleep apnea syndrome (OSA) and hypercoagulability – What is the impact of sole OSA in the absence of comorbities?
Source: Annual Congress 2013 –Sleep disordered breathing in special situations I
Year: 2013

Obstructive sleep apnoea in patients with type 1 diabetes
Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing
Year: 2013


Transition from obstructive sleep apnea (OSA) to obesity hypoventilation syndrome (OHS)
Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies
Year: 2015


Gender differences in comorbidity burden in recently diagnosed obstructive sleep apnea patients
Source: International Congress 2014 – Sleep disordered breathing 1
Year: 2014

Nocturia is an independent predictive factor of prevalent hypertension in obstructive sleep apnea patients
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014